ITPKC as a Prognostic and Predictive Biomarker of Neoadjuvant Chemotherapy for Triple Negative Breast Cancer

ITPKC as a Prognostic and Predictive Biomarker of Neoadjuvant Chemotherapy for Triple Negative Breast Cancer

Triple negative breast cancer (TNBC) is the most aggressive subtype of breast cancer with higher mortality than the others. Pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) is considered as a surrogate to predict survival. Inositol 1,4,5-trisphosphate 3-kinase C (<i>ITPKC...

Full description

Bibliographic Details
Main Authors: Masanori Oshi, Stephanie Newman, Vijayashree Murthy, Yoshihisa Tokumaru, Li Yan, Ryusei Matsuyama, Itaru Endo, Kazuaki Takabe
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Cancers
Subjects:
biomarker
breast cancer
gene expression
metastasis
survival
ITPKC
Online Access:https://www.mdpi.com/2072-6694/12/10/2758

Internet

https://www.mdpi.com/2072-6694/12/10/2758

Similar Items